Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAM-315
Clinical trial NCT00474552 · TERMINATED
Trial details
- NCT number
- NCT00474552
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-06-01
- Primary completion
- 2007-10-01
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.